Digital Therapeutics

Digital therapeutic tools to augment or replace traditional therapies.

LUX TAKE:

Digital therapeutics can replace or augment current modes of care like pharmaceuticals, physical therapy, or mental health services. They enable the transformation of healthcare by bringing medical care to patients in a scalable, low-cost way, but most companies are in their adolesence and have yet to verify their value proposition. However, with emerging digital dispensaries lowering the bar for ...

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent digital therapeutics developments.

News Commentaries

Singaporean startup Biofourmis gets its second FDA approval in the space of six months (October 4, 2019)

Kaia Health receives $8 million in funding for treatment of musculoskeletal disorders, targets U.S. and APAC regions (September 30, 2019)

New Lux Content

Kaia Health (September 30, 2019)

Wellthy Therapeutics (July 25, 2019)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	Proteus Digital Health, Akili Interactive Labs, Tivic Health, Dthera Sciences, Click Therapeutics, Better Therapeutics, Kaia Health, MedRhythms, Cognoa

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978